Skip to main content
SpringerLink
Log in

Approach to Effusion Cytology

  • Chapter
  • First Online:
Practical Diagnostic Approaches in Non-Gynaecologic Cytology

  • 620 Accesses

Abstract

Serous effusions may be the source of some diagnostic dilemmas due to overlapping cytomorphological findings and a dearth of clinical history. This chapter provides an overview of the spread of benign and malignant conditions that may be encountered in effusion cytology and focuses on some key questions.

The points of distinction between reactive mesothelial and carcinoma are addressed, as well as reactive vs. malignant mesothelial cells. A summary of the helpful panels for specific diagnostic dilemmas is provided, including an update on the various immunohistochemical and molecular markers for mesothelioma.

Finally, specific diagnostic pitfalls are highlighted, along with helpful tips and clues.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Light RW, Macgregor MI, Luchsinger PC, Ball WC. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972;77(4):507–13.

    Article  CAS  PubMed  Google Scholar 

  2. Chandra A, Crothers B, Kurtycz D, Schmitt F. Announcement: the international system for reporting serous fluid cytopathology. Acta Cytol. 2019;24:1–3.

    Google Scholar 

  3. Farahani SJ, Baloch Z. Are we ready to develop a tiered scheme for the effusion cytology? A comprehensive review and analysis of the literature. Diagn Cytopathol. 2019;47(11):1145–59.

    Article  PubMed  Google Scholar 

  4. Bibbo M, Wilbur DC. Comprehensive cytopathology. London: Elsevier Health Stock; 2015.

    Google Scholar 

  5. Haack LA, Selvaggi SM. ‘Daisy’ cells in peritoneal washings. Acta Cytol. 2003;47(5):949–50.

    PubMed  Google Scholar 

  6. Rooper LM, Ali SZ, Olson MT. A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: a retrospective analysis of 2540 cases. Cancer Cytopathol. 2014;122(9):657–65.

    Article  PubMed  Google Scholar 

  7. Swiderek J, Morcos S, Donthireddy V, Surapaneni R, Jackson-Thompson V, Schultz L, et al. Prospective study to determine the volume of pleural fluid required to diagnose malignancy. Chest. 2010;137(1):68–73.

    Article  PubMed  Google Scholar 

  8. Dejmek A, Zendehrokh N, Tomaszewska M, Edsjö A. Preparation of DNA from cytological material: effects of fixation, staining, and mounting medium on DNA yield and quality. Cancer Cytopathol. 2013;121(7):344–53.

    Article  CAS  PubMed  Google Scholar 

  9. Engels M, Michael C, Dobra K, Hjerpe A, Fassina A, Firat P. Management of cytological material, pre-analytical procedures and bio-banking in effusion cytopathology. Cytopathology. 2019;30(1):31–8.

    Article  PubMed  Google Scholar 

  10. Bubendorf L, Lantuejoul S, de Langen AJ, Thunnissen E. Nonsmall cell lung carcinoma: diagnostic difficulties in small biopsies and cytological specimens: number 2 in the series ‘pathology for the clinician’ edited by Peter Dorfmüller and Alberto Cavazza. Eur Respir Rev. 2017;26(144).

    Google Scholar 

  11. Jiang J, Shi H-Z, Liang Q-L, Qin S-M, Qin X-J. Diagnostic value of interferon-gamma in tuberculous pleurisy: a metaanalysis. Chest. 2007;131(4):1133–41.

    Article  CAS  PubMed  Google Scholar 

  12. Liang Q-L, Shi H-Z, Wang K, Qin S-M, Qin X-J. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med. 2008;102(5):744–54.

    Article  PubMed  Google Scholar 

  13. Bailey M, Eapen G, Ost D, Casal RF, Jimenez C, Datar S, et al. Routine microbiologic studies of pleural fluid specimens in cancer patients. Am J Med. 2020;133(2):240–4.

    Article  CAS  PubMed  Google Scholar 

  14. Barnes TW, Olson EJ, Morgenthaler TI, Edson RS, Decker PA, Ryu JH. Low yield of microbiologic studies on pleural fluid specimens. Chest. 2005;127(3):916–21.

    Article  PubMed  Google Scholar 

  15. Krenke R, Maskey-Warzechowska M, Korczynski P, Zielinska-Krawczyk M, Klimiuk J, Chazan R, et al. Pleural effusion in Meigs’ syndrome-transudate or exudate?: systematic review of the literature. Medicine (Baltimore). 2015;94(49):e2114.

    Google Scholar 

  16. Maskell NA, Butland RJA, Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax. 2003;58(Suppl 2):ii8–17.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Townsend SR. Syndrome of ovarian tumour associated with ascites and pleural effusion: (Meigs’ syndrome). Can Med Assoc J. 1945;53(3):245–7.

    Google Scholar 

  18. Thirkell D, Taylor JH, Ingram CG. MEIGS’ syndrome: a case report. J Coll Gen Pract. 1963;6:400–7.

    Google Scholar 

  19. Berger HW, Seckler SG. Pleural and pericardial effusions in rheumatoid disease. Ann Intern Med. 1966;64(6):1291–7.

    Article  CAS  PubMed  Google Scholar 

  20. Toubes ME, Lama A, Ferreiro L, Golpe A, Álvarez-Dobaño JM, González-Barcala FJ, et al. Urinothorax: a systematic review. J Thorac Dis. 2017;9(5):1209–18.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Demay RM. The art and science of cytopathology. Chicago: American Society of Clinical Pathology; 2012.

    Google Scholar 

  22. Whitaker D. The cytology of malignant mesothelioma. Cytopathology. 2000;11(3):139–51.

    Article  CAS  PubMed  Google Scholar 

  23. Wojcik EM, Naylor B. ‘Collagen balls’ in peritoneal washings. Prevalence, morphology, origin and significance. Acta Cytol. 1992;36(4):466–70.

    CAS  PubMed  Google Scholar 

  24. Hjerpe A, Ascoli V, Bedrossian C, Boon M, Creaney J, Davidson B, et al. Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology. CytoJournal. 2015;12:26.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Whitaker D, Shilkin KB. Diagnosis of pleural malignant mesothelioma in life—a practical approach. J Pathol. 1984;143(3):147–75.

    Article  CAS  PubMed  Google Scholar 

  26. Gao L, Reeves W, Demay RM. Parakeratotic-like cells in effusions—a clue to diagnosis of malignant mesothelioma. CytoJournal. 2012;9:18.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Mok Y, Nga ME. Cytomorphological changes induced by intraperitoneal chemotherapy present important diagnostic pitfalls in peritoneal fluid cytology. Cytopathology. 2017;28(4):299–306.

    Article  CAS  PubMed  Google Scholar 

  28. Patel T, Patel P, Mehta S, Shah M, Jetly D, Khanna N. The value of cytology in diagnosis of serous effusions in malignant lymphomas: an experience of a tertiary care center. Diagn Cytopathol. 2019;47(8):776–82.

    PubMed  Google Scholar 

  29. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (Eds). WHO Classification of Tumours of Haematopoeitic and Lymphoid Tissues (Revised 4th edition). IARC: Lyon 2017.

    Google Scholar 

  30. Ishida M, Kagotani A, Iwai M. Cytological features of lung adenocarcinoma with micropapillary pattern in the pleural or pericardial effusion: analysis of 5 cases. Int J Clin Exp Pathol. 2014;7(8):5111–6.

    PubMed  PubMed Central  Google Scholar 

  31. Parwani AV, Chan TY, Ali SZ. Significance of psammoma bodies in serous cavity fluid: a cytopathologic analysis. Cancer. 2004;102(2):87–91.

    Article  PubMed  Google Scholar 

  32. Atahan S, Ekinci C, Içli F, Erdoğan N. Cytology of clear cell carcinoma of the female genital tract in fine needle aspirates and ascites. Acta Cytol. 2000;44(6):1005–9.

    Article  CAS  PubMed  Google Scholar 

  33. Damiani D, Suciu V, Genestie C, Vielh P. Cytomorphology of ovarian clear cell carcinomas in peritoneal effusions. Cytopathology. 2016;27(6):427–32.

    Article  CAS  PubMed  Google Scholar 

  34. Karatziou C, Pitta X, Stergiouda T, Karadimou V, Termentzis G. A case of extraskeletal Ewing sarcoma originating from the visceral pleura. Hippokratia. 2011;15(4):363–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Ikeda K, Tsuta K. Effusion cytomorphology of small round cell tumors. J Cytol. 2016;33(2):85–92.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Nosanchuk JS, Naylor B. A unique cytologic picture in pleural fluid from patients with rheumatoid arthritis. Am J Clin Pathol. 1968;50(3):330–5.

    Article  CAS  PubMed  Google Scholar 

  37. Carmichael DS, Golding DN. Rheumatoid pleural effusion with ‘R.A. cells’ in the pleural fluid. Br Med J. 1967;2(5555):814.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Naylor B. Cytological aspects of pleural, peritoneal and pericardial fluids from patients with systemic lupus erythematosus. Cytopathology. 1992;3(1):1–8.

    Article  CAS  PubMed  Google Scholar 

  39. AbdullGaffar B. Eosinophilic effusions: a clinicocytologic study of 12 cases. Diagn Cytopathol. 2018;46(12):1015–21.

    Article  PubMed  Google Scholar 

  40. Meagher NS, Wang L, Rambau PF, Intermaggio MP, Huntsman DG, Wilkens LR, et al. A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases. Mod Pathol [Internet]. 2019 [cited 2019 Oct 28]. http://www.nature.com/articles/s41379-019-0302-0.

  41. Khalbuss WE, Hooda S, Auger M. Cytomorphology of Boerhaave’s syndrome: a critical value in cytology. CytoJournal. 2013;10:8.

    Google Scholar 

  42. Pai RK, West RB. MOC-31 exhibits superior reactivity compared with Ber-EP4 in invasive lobular and ductal carcinoma of the breast: a tissue microarray study. Appl Immunohistochem Mol Morphol. 2009;17(3):202–6.

    Article  CAS  PubMed  Google Scholar 

  43. Creaney J, Segal A, Sterrett G, Platten MA, Baker E, Murch AR, et al. Overexpression and altered glycosylation of MUC1 in malignant mesothelioma. Br J Cancer. 2008;98(9):1562–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Hasteh F, Lin GY, Weidner N, Michael CW. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Cancer Cytopathol. 2010;118(2):90–6.

    Article  PubMed  Google Scholar 

  45. Churg A, Sheffield BS, Galateau-Salle F. New markers for separating benign from malignant mesothelial proliferations: are we there yet? Arch Pathol Lab Med. 2016;140(4):318–21.

    Article  CAS  PubMed  Google Scholar 

  46. Cigognetti M, Lonardi S, Fisogni S, Balzarini P, Pellegrini V, Tironi A, et al. BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations. Mod Pathol. 2015;28(8):1043–57.

    Article  CAS  PubMed  Google Scholar 

  47. Kinoshita Y, Hida T, Hamasaki M, Matsumoto S, Sato A, Tsujimura T, et al. A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma. Cancer Cytopathol. 2018;126(1):54–63.

    Article  CAS  PubMed  Google Scholar 

  48. Kinoshita Y, Hamasaki M, Yoshimura M, Matsumoto S, Sato A, Tsujimura T, et al. A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis. Lung Cancer. 2018;125:198–204.

    Article  PubMed  Google Scholar 

  49. Hida T, Hamasaki M, Matsumoto S, Sato A, Tsujimura T, Kawahara K, et al. Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: comparison with 9p21 FISH and BAP1 immunohistochemistry. Lung Cancer. 2017;104:98–105.

    Article  PubMed  Google Scholar 

  50. Ikeda K, Tate G, Suzuki T, Kitamura T, Mitsuya T. Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations. Diagn Cytopathol. 2011;39(6):395–401.

    Article  PubMed  Google Scholar 

  51. Minato H, Kurose N, Fukushima M, Nojima T, Usuda K, Sagawa M, et al. Comparative immunohistochemical analysis of IMP3, GLUT1, EMA, CD146, and desmin for distinguishing malignant mesothelioma from reactive mesothelial cells. Am J Clin Pathol. 2014;141(1):85–93.

    Article  PubMed  Google Scholar 

  52. Sato A, Torii I, Okamura Y, Yamamoto T, Nishigami T, Kataoka TR, et al. Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium. Mod Pathol. 2010;23(11):1458–66.

    Article  CAS  PubMed  Google Scholar 

  53. Flores-Staino C, Darai-Ramqvist E, Dobra K, Hjerpe A. Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions. Lung Cancer. 2010;68(1):39–43.

    Article  PubMed  Google Scholar 

  54. Adell E, Dejmek A. Telomerase activity analyzed with TRAP in situ provides additional information in effusions remaining equivocal after immunocytochemistry and hyaluronan analysis. Diagn Cytopathol. 2014;42(12):1051–7.

    Article  PubMed  Google Scholar 

  55. Cakir C, Gulluoglu MG, Yilmazbayhan D. Cell proliferation rate and telomerase activity in the differential diagnosis between benign and malignant mesothelial proliferations. Pathology (Phila). 2006;38(1):10–5.

    CAS  Google Scholar 

  56. Kumaki F, Kawai T, Churg A, Galateau-Sallé FB, Hasleton P, Henderson D, et al. Expression of telomerase reverse transcriptase (TERT) in malignant mesotheliomas. Am J Surg Pathol. 2002;26(3):365–70.

    Article  PubMed  Google Scholar 

  57. Churg A, Nabeshima K, Ali G, Bruno R, Fernandez-Cuesta L, Galateau-Salle F. Highlights of the 14th international mesothelioma interest group meeting: pathologic separation of benign from malignant mesothelial proliferations and histologic/molecular analysis of malignant mesothelioma subtypes. Lung Cancer. 2018;124:95–101.

    Article  PubMed  Google Scholar 

  58. Bruno R, Alì G, Giannini R, Proietti A, Lucchi M, Chella A, et al. Malignant pleural mesothelioma and mesothelial hyperplasia: a new molecular tool for the differential diagnosis. Oncotarget. 2017;8(2):2758–70.

    Article  PubMed  Google Scholar 

  59. Renshaw AA, Comiter CV, Nappi D, Granter SR. Effusion cytology of renal cell carcinoma. Cancer. 1998;84(3):148–52.

    Article  CAS  PubMed  Google Scholar 

  60. Hoeltermann W, Schlotmann-Hoeller E, Winkelmann M, Pfitzer P. Lavage fluid from continuous ambulatory peritoneal dialysis. A model for mesothelial cell changes. Acta Cytol. 1989;33(5):591–4.

    CAS  PubMed  Google Scholar 

  61. Selvaggi SM, Migdal S. Cytologic features of atypical mesothelial cells in peritoneal dialysis fluid. Diagn Cytopathol. 1990;6(1):22–6.

    Article  CAS  PubMed  Google Scholar 

  62. Carlon G, Della Giustina D. Atypical mesothelial cells in peritoneal dialysis fluid. Acta Cytol. 1983;27(6):706–8.

    CAS  PubMed  Google Scholar 

  63. Fok FK, Bewtra C, Hammeke MD. Cytology of peritoneal fluid from patients on continuous ambulatory peritoneal dialysis. Acta Cytol. 1989;33(5):595–8.

    CAS  PubMed  Google Scholar 

  64. Boerner SL. Mimicry and pitfalls in effusion cytology. Pathol Case Rev. 2006;11(2):85–91.

    Article  Google Scholar 

  65. Saphir O. Cytologic diagnosis of cancer from pleural and peritoneal fluids. Am J Clin Pathol. 1949;19(4):309–14.

    Article  CAS  PubMed  Google Scholar 

  66. Kutty CP, Remeniuk E, Varkey B. Malignant-appearing cells in pleural effusion due to pancreatitis: case report and literature review. Acta Cytol. 1981;25(4):412–6.

    CAS  PubMed  Google Scholar 

  67. Kitayama J. Intraperitoneal chemotherapy against peritoneal carcinomatosis: current status and future perspective. Surg Oncol. 2014;23(2):99–106.

    Article  PubMed  Google Scholar 

  68. Sevinç S, Unsal S, Oztürk T, Uysal A, Samancilar O, Kaya SO, et al. Thoracic endometriosis syndrome with bloody pleural effusion in a 28 year old woman. JPMA J Pak Med Assoc. 2013;63(1):114–6.

    PubMed  Google Scholar 

  69. Kobayashi TK, Moritani S, Urabe M, Bamba M, Ueda M, Nishino T, et al. Cytologic diagnosis of endosalpingiosis with pregnant women presenting in peritoneal fluid: a case report. Diagn Cytopathol. 2004;30(6):422–5.

    Article  PubMed  Google Scholar 

  70. Sneige N, Dawlett MA, Kologinczak TL, Guo M. Endosalpingiosis in peritoneal washings in women with benign gynecologic conditions: thirty-eight cases confirmed with paired box-8 immunohistochemical staining and correlation with surgical biopsy findings. Cancer Cytopathol. 2013;121(10):582–90.

    Article  PubMed  Google Scholar 

  71. Gaulier A, Jouret-Mourin A, Marsan C. Peritoneal endometriosis. Report of a case with cytologic, cytochemical and histopathologic study. Acta Cytol. 1983;27(4):446–9.

    CAS  PubMed  Google Scholar 

  72. Iyer V, Mathur S, Arava S. Cytological diagnosis of peritoneal endometriosis. J Cytol. 2010;27(2):77.

    Article  PubMed  PubMed Central  Google Scholar 

  73. LePhong C, Hubbard EW, Van Meter S, Nodit L. Squamous cell carcinoma in serous effusions: avoiding pitfalls in this rare encounter. Diagn Cytopathol. 2017;45(12):1095–9.

    Article  PubMed  Google Scholar 

  74. Huang CC, Michael CW. Cytomorphological features of metastatic squamous cell carcinoma in serous effusions. Cytopathology. 2014;25(2):112–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, National University Hospital, Singapore, Singapore

    Min En Nga

Authors
  1. Min En Nga
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Min En Nga .

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nga, M.E. (2021). Approach to Effusion Cytology. In: Practical Diagnostic Approaches in Non-Gynaecologic Cytology. Springer, Singapore. https://doi.org/10.1007/978-981-15-2961-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-2961-0_9

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-2960-3

  • Online ISBN: 978-981-15-2961-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation